MA
AWH

MYDA Advisors’s Aspira Women's Health Inc. Common Stock AWH Stock Holding History

MYDA Advisors’s Portfolio AWH Stock Details AWH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-2,667
Closed -$270K – 355
2021
Q1 		$270K Buy
+2,667
New +$293K 0.07% 229

Other funds holding AWH

OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PGM
Parian Global Management Pound Ridge, New York $30.8M AUM 51.25% 1-Year Est. Return
FA
Friess Associates Greenville, Delaware $59.9M AUM 3.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ACM
ACT Capital Management Wayne, Pennsylvania $127M AUM
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BRWM
B. Riley Wealth Management Memphis, Tennessee $85.5M AUM 3.46% 1-Year Est. Return

MYDA Advisors's AWH Position: Q2 2021 in Review

MYDA Advisors sold out of Aspira Women's Health Inc. Common Stock (AWH) in Q2 2021, closing a stake of 2,667 shares — an estimated $270K sold.

MYDA Advisors first reported a position in AWH in Q1 2021 and held it in 1 quarter. The position peaked at $270K in Q1 2021. 95 funds tracked by Wall St. Rank hold AWH as of Q2 2021.

  • MYDA Advisors reported no remaining Aspira Women's Health Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
  • MYDA Advisors sold 2,667 Aspira Women's Health Inc. Common Stock shares in Q2 2021, an estimated $270K.
  • MYDA Advisors first reported a position in Aspira Women's Health Inc. Common Stock in Q1 2021 and held it in 1 quarter.
  • MYDA Advisors's Aspira Women's Health Inc. Common Stock position peaked at $270K in Q1 2021.
  • 95 funds tracked by Wall St. Rank held Aspira Women's Health Inc. Common Stock as of Q2 2021.

Based on MYDA Advisors's 13F filing for Q2 2021, filed 13 Aug 2021.